JWM
TGTX icon

JPL Wealth Management’s TG Therapeutics TGTX Stock Holding History

JPL Wealth Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.75K Hold
50
– – ﹤0.01% 970
2026
Q1 		$1.66K Buy
+50
New +$1.49K ﹤0.01% 1030
2025
Q4 		– Sell
-45
Closed -$1.63K – 1019
2025
Q3 		$1.63K Buy
+45
New +$1.48K ﹤0.01% 904

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

JPL Wealth Management's TGTX Position: Q2 2026 in Review

JPL Wealth Management held its TG Therapeutics (TGTX) position steady in Q2 2026 at 50 shares worth $2.75K. The position accounts for ﹤0.01% of the portfolio, ranked #970.

JPL Wealth Management first reported a position in TGTX in Q3 2025 and has held it in 3 quarters since. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • JPL Wealth Management held 50 shares of TG Therapeutics worth $2.75K as of Q2 2026.
  • JPL Wealth Management left its TG Therapeutics share count unchanged in Q2 2026.
  • TG Therapeutics made up ﹤0.01% of JPL Wealth Management's portfolio in Q2 2026, its #970 holding.
  • JPL Wealth Management first reported a position in TG Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.